BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 29351391)

  • 1. The bile acids, deoxycholic acid and ursodeoxycholic acid, regulate colonic epithelial wound healing.
    Mroz MS; Lajczak NK; Goggins BJ; Keely S; Keely SJ
    Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G378-G387. PubMed ID: 29351391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile acids deoxycholic acid and ursodeoxycholic acid differentially regulate human β-defensin-1 and -2 secretion by colonic epithelial cells.
    Lajczak NK; Saint-Criq V; O'Dwyer AM; Perino A; Adorini L; Schoonjans K; Keely SJ
    FASEB J; 2017 Sep; 31(9):3848-3857. PubMed ID: 28487283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Farnesoid X receptor agonists attenuate colonic epithelial secretory function and prevent experimental diarrhoea in vivo.
    Mroz MS; Keating N; Ward JB; Sarker R; Amu S; Aviello G; Donowitz M; Fallon PG; Keely SJ
    Gut; 2014 May; 63(5):808-17. PubMed ID: 23916961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon.
    Ward JBJ; Lajczak NK; Kelly OB; O'Dwyer AM; Giddam AK; Ní Gabhann J; Franco P; Tambuwala MM; Jefferies CA; Keely S; Roda A; Keely SJ
    Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G550-G558. PubMed ID: 28360029
    [No Abstract]   [Full Text] [Related]  

  • 5. The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion.
    Lew JL; Zhao A; Yu J; Huang L; De Pedro N; Peláez F; Wright SD; Cui J
    J Biol Chem; 2004 Mar; 279(10):8856-61. PubMed ID: 14684751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mechanism for gut barrier dysfunction by dietary fat: epithelial disruption by hydrophobic bile acids.
    Stenman LK; Holma R; Eggert A; Korpela R
    Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(3):G227-34. PubMed ID: 23203158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological HIF-1 stabilization promotes intestinal epithelial healing through regulation of α-integrin expression and function.
    Goggins BJ; Minahan K; Sherwin S; Soh WS; Pryor J; Bruce J; Liu G; Mathe A; Knight D; Horvat JC; Walker MM; Keely S
    Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G420-G438. PubMed ID: 33470153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnane X receptor agonists enhance intestinal epithelial wound healing and repair of the intestinal barrier following the induction of experimental colitis.
    Terc J; Hansen A; Alston L; Hirota SA
    Eur J Pharm Sci; 2014 May; 55():12-9. PubMed ID: 24486481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bile acids on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced aberrant crypt foci and DNA adduct formation in the rat colon.
    Ueyama Y; Monden Y; He XB; Lin CX; Momen MA; Mimura S; Umemoto A
    J Exp Clin Cancer Res; 2002 Dec; 21(4):577-83. PubMed ID: 12636105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deoxycholic acid delays the wound healing of colonic epithelial cells via transmembrane G-protein-coupled receptor 5.
    Azuma Y; Uchiyama K; Sugaya T; Yasuda T; Hashimoto H; Kajiwara-Kubota M; Sugino S; Kitae H; Torii T; Mizushima K; Doi T; Inoue K; Dohi O; Yoshida N; Kamada K; Ishikawa T; Takagi T; Konishi H; Naito Y; Itoh Y
    J Gastroenterol Hepatol; 2022 Jan; 37(1):134-143. PubMed ID: 34477242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposing effects of bile acids deoxycholic acid and ursodeoxycholic acid on signal transduction pathways in oesophageal cancer cells.
    Abdel-Latif MM; Inoue H; Reynolds JV
    Eur J Cancer Prev; 2016 Sep; 25(5):368-79. PubMed ID: 26378497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farnesoid X receptor signal is involved in deoxycholic acid-induced intestinal metaplasia of normal human gastric epithelial cells.
    Li S; Chen X; Zhou L; Wang BM
    Oncol Rep; 2015 Nov; 34(5):2674-82. PubMed ID: 26324224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodeoxycholic Acid Suppresses Lipogenesis in Mouse Liver: Possible Role of the Decrease in β-Muricholic Acid, a Farnesoid X Receptor Antagonist.
    Fujita K; Iguchi Y; Une M; Watanabe S
    Lipids; 2017 Apr; 52(4):335-344. PubMed ID: 28315136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The secondary bile acids, ursodeoxycholic acid and lithocholic acid, protect against intestinal inflammation by inhibition of epithelial apoptosis.
    Lajczak-McGinley NK; Porru E; Fallon CM; Smyth J; Curley C; McCarron PA; Tambuwala MM; Roda A; Keely SJ
    Physiol Rep; 2020 Jun; 8(12):e14456. PubMed ID: 32562381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile acids modulate the Golgi membrane fission process via a protein kinase Ceta and protein kinase D-dependent pathway in colonic epithelial cells.
    Byrne AM; Foran E; Sharma R; Davies A; Mahon C; O'Sullivan J; O'Donoghue D; Kelleher D; Long A
    Carcinogenesis; 2010 Apr; 31(4):737-44. PubMed ID: 20093383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of individual bile acids in vivo utilizing a novel low bile acid mouse model.
    Taylor R; Yang Z; Henry Z; Capece G; Meadows V; Otersen K; Basaly V; Bhattacharya A; Mera S; Zhou P; Joseph L; Yang I; Brinker A; Buckley B; Kong B; Guo GL
    Toxicol Sci; 2024 May; 199(2):316-331. PubMed ID: 38526215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production.
    Rodrigues CM; Fan G; Wong PY; Kren BT; Steer CJ
    Mol Med; 1998 Mar; 4(3):165-78. PubMed ID: 9562975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to ursodeoxycholic acid-induced growth arrest can also result in resistance to deoxycholic acid-induced apoptosis and increased tumorgenicity.
    Powell AA; Akare S; Qi W; Herzer P; Jean-Louis S; Feldman RA; Martinez JD
    BMC Cancer; 2006 Sep; 6():219. PubMed ID: 16948850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acid treatment and FXR agonism lower postprandial lipemia in mice.
    Farr S; Stankovic B; Hoffman S; Masoudpoor H; Baker C; Taher J; Dean AE; Anakk S; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2020 Apr; 318(4):G682-G693. PubMed ID: 32003602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of Adenomatous Polyposis Coli Reduces Bile Acid/Farnesoid X Receptor Expression through Fxr gene CpG Methylation in Mouse Colon Tumors and Human Colon Cancer Cells.
    Selmin OI; Fang C; Lyon AM; Doetschman TC; Thompson PA; Martinez JD; Smith JW; Lance PM; Romagnolo DF
    J Nutr; 2016 Feb; 146(2):236-42. PubMed ID: 26609171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.